医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Severe acute respiratory syndrome coronavirus-2-related and imputable deaths in children:results from the French pediatric national registry

摘要Background Severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)is responsible for an important mortality rate worldwide.We aimed to evaluate the actual imputability of SARS-CoV-2 on the mortality rate associated with SARS-CoV-2-related illnesses in the pediatric intensive care unit(PICU).Secondary objectives were to identify risk factors for death.Methods This national multicenter comparative study comprised all patients under 18 years old with positive SARS-CoV-2 polymerase chain reactions(PCRs)[acute corona virus disease 2019(COVID-19)or incidental SARS-CoV-2 infection]and/or pediatric inflammatory multisystem syndrome(PIMS)recorded in the French PICU registry(PICURe)between September 1,2021,and August 31,2022.Included patients were classified and compared according to their living status at the end of their PICU stay.Deceased patients were evaluated by four experts in the field of pediatric infectiology and/or pediatric intensive care.The imputability of SARS-CoV-2 as the cause of death was classified into four categories:certain,very probable,possible,or unlikely,and was defined by any of the first threecategories.Results There were 948 patients included of which 43 died(4.5%).From this,26 deaths(67%)could be attributed to SARS-CoV-2 infection,with an overall mortality rate of 2.8%.The imputability of death to SARS-CoV-2 was considered certain in only one case(0.1%).Deceased patients suffered more often from comorbidities,especially heart disease,neurological disorders,hematological disease,cancer,and obesity.None of the deceased patients were admitted for pediatric inflam-matory multisystem syndrome(PIMS).Mortality risk factors were male gender,cardiac comorbidities,cancer,and acute respiratory distress syndrome.Conclusions SARS-CoV-2 mortality in the French pediatric population was low.Even though the imputability of SARS-CoV-2 on mortality was considered in almost two-thirds of cases,this imputability was considered certain in only one case.

更多
广告
作者 Marguerite Lockhart-Bouron [1] Noémie Vanel [2] Michael Levy [3] Ana?s R.Briant [4] Etienne Javouhey [5] Sophie Breinig [6] Julia Dina [7] Marion Caseris [8] Fran?ois Angoulvant [9] Stéphane Leteurtre [1] Morgan Recher [1] David W.Brossier [10] 学术成果认领
作者单位 Univ.Lille,CHU Lille,ULR 2694-METRICS:évaluation Des Technologies de Santé Et Des Pratiques Médicales,59000 Lille,France [1] Pediatric Intensive Care Unit,CHU de Marseille,Marseille,France [2] Pediatric Intensive Care Unit,CHU Robert-Debré,Assistance Publique H?pitaux de Paris,Paris,France;Université Paris-Cité,Paris,France [3] Biostatistics and Clinical Research Unit,CHU de Caen Normandie,14000 Caen,France [4] Pediatric Intensive Care,Hospices Civils de Lyon,Lyon,France [5] Neonatal and Pediatric Intensive Care Unit,Children's Hospital,Toulouse,France [6] Virology Department,INSERM U1311 Dynamicure,Univ CAEN Normandie,CHU de Caen,14000 Caen,France;Medical School,Université Caen Normandie,14000 Caen,France [7] Department of Pediatrics,CHU Robert-Debré,Assistance Publique H?pitaux de Paris,Paris,France [8] Department Women-Mother-Child,Service of Pediatrics,Lausanne University Hospital(CHUV),Lausanne,Switzerland [9] Univ.Lille,CHU Lille,ULR 2694-METRICS:évaluation Des Technologies de Santé Et Des Pratiques Médicales,59000 Lille,France;Medical School,Université Caen Normandie,14000 Caen,France;Pediatric Intensive Care Unit,Réanimation Et Soins Intensifs Pédiatriques,CHU de CAEN,Avenue de La Cote de Nacre,14000 Caen,France;CHU Sainte Justine Research Center,Montréal,Canada [10]
栏目名称
DOI 10.1007/s12519-023-00791-x
发布时间 2024-08-14(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览5
  • 下载0
世界儿科杂志(英文版)

世界儿科杂志(英文版)

2024年20卷6期

611-620页

SCIMEDLINEISTICCSCD

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷